Literature DB >> 11823714

Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist.

Michiko Nakamura1, Kazuhiko Nakakimura, Mishiya Matsumoto, Takefumi Sakabe.   

Abstract

Two types of ischemic tolerance in the brain, rapid and delayed, have been reported in terms of the interval between the conditioning and test insults. Although many reports showed that delayed-phase neuroprotection evoked by preconditioning is evident after 1 week or longer, there have been a few investigations about rapidly induced tolerance, and the reported neuroprotective effects become ambiguous 7 days after the insults. The authors examined whether this rapid ischemic tolerance exists after 7 days of reperfusion in a rat focal ischemic model, and investigated modulating effects of the adenosine A 1 receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine). Preconditioning with 30 minutes of middle cerebral artery occlusion reduced infarct volume 7 days after 180 minutes of subsequent focal ischemia given after 1-hour reperfusion. The rapid preconditioning also improved neurologic outcome. These beneficial effects were attenuated by pretreatment of 0.1 mg/kg DPCPX, which did not influence the infarct volume after conditioning (30 minutes) or test (180 minutes) ischemia when given alone. The results show that preconditioning with a brief focal ischemia induces rapid tolerance to a subsequent severe ischemic insult, the effect of which is still present after 7 days of reperfusion, and that the rapid ischemic tolerance is possibly mediated through an adenosine A 1 receptor-related mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823714     DOI: 10.1097/00004647-200202000-00004

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  24 in total

Review 1.  Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia.

Authors:  Miguel A Pérez-Pinzón
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.

Authors:  Robert Meller; Jennifer Anastasia Cameron; Daniel John Torrey; Corrin Erin Clayton; Andrea Nicole Ordonez; David Clifford Henshall; Manabu Minami; Clara Kay Schindler; Julie Anne Saugstad; Roger Pancoast Simon
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

3.  Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat.

Authors:  V Haktan Ozacmak; Hale Sayan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 4.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

5.  Presynaptic silencing is an endogenous neuroprotectant during excitotoxic insults.

Authors:  Joshua Hogins; Devon C Crawford; Xiaoping Jiang; Steven Mennerick
Journal:  Neurobiol Dis       Date:  2011-05-14       Impact factor: 5.996

6.  Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory.

Authors:  Ana Patrícia Simões; Nuno J Machado; Nélio Gonçalves; Manuella P Kaster; Ana T Simões; Ana Nunes; Luís Pereira de Almeida; Ki Ann Goosens; Daniel Rial; Rodrigo A Cunha
Journal:  Neuropsychopharmacology       Date:  2016-06-17       Impact factor: 7.853

7.  Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.

Authors:  Anna Maria Pugliese; Serena Latini; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

Review 8.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

9.  Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.

Authors:  Rebecca L Williams-Karnesky; Mary P Stenzel-Poore
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.